Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2010
09/21/2010US7799898 Human transferase family members and uses thereof
09/21/2010US7799562 Hybridoma producing antibodies to lawsonia intracellularis
09/21/2010US7799543 Human tumor necrosis factor receptor polynucleotides
09/21/2010US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction
09/21/2010US7799529 Nephrin gene and protein
09/21/2010US7799327 Employing nonimmunogenic blood products from patients with autoimmune disease
09/21/2010CA2369292C Method of modulating the activity of functional immune molecules
09/21/2010CA2367457C Protein for blocking platelet adhesion
09/21/2010CA2345403C Detection of preharvest sprouting in cereal grains
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2323756C Genetic engineering salt tolerance in crop plants
09/21/2010CA2308791C Method to screen phage display libraries with different ligands
09/21/2010CA2225788C Therapeutic agents and autoimmune diseases
09/21/2010CA2211578C Muscle protein proteolysis inhibiting agent containing il-6 receptor antibody
09/21/2010CA2192694C Cloning and expression of an acetylcholine-gated ion channel receptor subunit
09/21/2010CA2172145C Metal complexes with a charged linker
09/17/2010CA2658714A1 Hcv-derived polypeptides and uses thereof
09/16/2010WO2010105256A1 Rationally designed, synthetic antibody libraries and uses therefor
09/16/2010WO2010104949A2 Anti-bcma antibodies
09/16/2010WO2010104815A1 Antibodies binding to pivka-ii amino acids 13-27
09/16/2010WO2010104761A2 Anti-cd40 antibodies and uses thereof
09/16/2010WO2010104749A2 Antigen presenting cell targeted cancer vaccines
09/16/2010WO2010104748A2 Antigen presenting cell targeted anti-viral vaccines
09/16/2010WO2010104747A2 Antigen presenting cell targeted vaccines
09/16/2010WO2010104245A1 Antibody specific to methicillin resistant staphylococcus aureus, detection method and kit for methicillin resistant staphylococcus aureus using the same
09/16/2010WO2010104208A1 Generation, expression and characterization of the humanized k33n monoclonal antibody
09/16/2010WO2010104052A1 Humanized pcrv antibody having anti-pseudomonal activity
09/16/2010WO2010103350A1 A method for predicting the responsiveness to an anti-tnf alpha antibody treatment
09/16/2010WO2010103284A1 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
09/16/2010WO2010103274A1 Antibody molecules having binding specificity for human il-13
09/16/2010WO2010087972A3 Il-1 binding proteins
09/16/2010WO2010079149A4 Fusion antibody
09/16/2010WO2010063783A3 Modulating xrn2
09/16/2010WO2010059689A3 Rsv f vlps and methods of manufacture and use thereof
09/16/2010WO2010055510A3 Diagnosis of multiple sclerosis
09/16/2010WO2010054377A3 Fully human antibodies against n-cadherin
09/16/2010WO2010051056A3 ANTI-FcεRI POLYPEPTIDES AND THEIR USES
09/16/2010WO2010033587A3 Methods for treating progressive multiple sclerosis
09/16/2010WO2010031551A3 Monoclonal antibodies for treatment of cancer
09/16/2010WO2010021697A3 Antibodies to ccr2
09/16/2010WO2009083225A3 Antibody-containing formulation for the use for treating cardiovascular diseases associated with atherosclerosis
09/16/2010US20100235933 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders
09/16/2010US20100235929 Compositions and Methods for Producing Antibodies Having Human Idiotypes in Transgenic Birds
09/16/2010US20100234581 Thermostable xylose isomerase enzymes
09/16/2010US20100234579 Silver nanoparticle binding agent conjugates based on moieties with triple cyclic disulfide anchoring groups
09/16/2010US20100234578 Anti-cd40 monoclonal antibody
09/16/2010US20100234577 Methods for purifying antibodies using ceramic hydroxyapatite
09/16/2010US20100234576 Human toll homologues
09/16/2010US20100234575 Fc variants with altered binding to fcrn
09/16/2010US20100234574 Fc Variants with altered binding to FcRn
09/16/2010US20100234573 Fc Variants with altered binding to FcRn
09/16/2010US20100234572 Fc Variants with altered binding to FcRn
09/16/2010US20100234571 Fc variants with altered binding to fcrn
09/16/2010US20100234570 Ligand
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/16/2010US20100234293 Novel Neurotrophic Factors
09/16/2010US20100234283 Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
09/16/2010US20100233819 Robo: a novel family of polypeptides and nucleic acids
09/16/2010US20100233803 Fusion Polypeptides Capable of Activating Receptors
09/16/2010US20100233781 Tubular nanostructure targeted to cell membrane
09/16/2010US20100233779 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
09/16/2010US20100233758 Protein increasing cell infectivity of herpes simplex virus and use thereof
09/16/2010US20100233737 Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker
09/16/2010US20100233731 Detection and measurement of blood-feeding activity
09/16/2010US20100233711 Gene encoding labyrinthin, a marker for cancer
09/16/2010US20100233690 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
09/16/2010US20100233249 Contraceptive methods and compositions related to proteasomal interference
09/16/2010US20100233191 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/16/2010US20100233189 Crystal structure
09/16/2010US20100233188 Antibodies and pharamcetical compositions containing same useful for inhibiting activity of metalloproteins
09/16/2010US20100233186 Novel receptor that binds ctla-8
09/16/2010US20100233183 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
09/16/2010US20100233182 Antibodies against Clostridium difficile toxins and uses thereof
09/16/2010US20100233181 Antibodies against clostridium difficile toxins and uses thereof
09/16/2010US20100233180 Antibodies that bind to an epitope on the huntington's disease protein
09/16/2010US20100233179 BAFF, inhibitors thereof and their use in the modulation of B-cell response
09/16/2010US20100233178 Use of antibodies for the vaccination against cancer
09/16/2010US20100233177 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
09/16/2010US20100233176 Methods and systems for predicting misfolded protein epitopes
09/16/2010US20100233175 Antibodies relating to pivkaii and uses thereof
09/16/2010US20100233174 Anthrax carbohydrates, synthesis and uses thereof
09/16/2010US20100233173 Multispecific epitope binding proteins and uses thereof
09/16/2010US20100233170 Fully human antibodies against N-Cadherin
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233167 Chain reaction creating oligomers from repeat units of binding molecules
09/16/2010US20100233165 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
09/16/2010US20100233160 Monoclonal Anti-Annexin A3 Antibodies for the Detection of Prostate Carcinoma
09/16/2010US20100233158 Induction of immune tolerance
09/16/2010US20100233157 Human antibodies against human fas and their use
09/16/2010US20100233155 Humanized anti-ccr2 antibodies and methods of use therefor
09/16/2010US20100233154 Targeted binding agents directed to heparanase and uses thereof 463
09/16/2010US20100233153 Novel gene disruptions, compositions and the methods relating thereto
09/16/2010US20100233152 Use of HMGB proteins and nucleic acids that code therefor
09/16/2010US20100233121 Method for treating multiple sclerosis
09/16/2010US20100233084 Method for Delivery Across the Blood Brain Barrier
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010CA2755219A1 Antibodies binding to pivka-ii amino acids 13-27
09/16/2010CA2754938A1 Anti-bcma antibodies
09/16/2010CA2754906A1 Antigen presenting cell targeted vaccines
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 1494